The Daily Record (Maryland)

New study finds travel delays don’t impact long-term outcomes for rare cancer patients

From left, Dr. Vadim Guschin, Director of Mercy’s heated chemotherapy (HIPEC) program and a member of the Surgical Oncology Department, and Armando Sardi, M.D., Medical Director of The Institute for ...
Medscape

Paclitaxel Matches Cisplatin HIPEC in Ovarian Cancer

Patients with advanced ovarian cancer undergoing interval cytoreductive surgery who received paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) during surgery appeared to have ...
Bay News 9

Tampa General Hospital study gives hope for ovarian cancer patients

TAMPA, Fla. — A new study of a cancer treatment called HIPEC, heated intraperitoneal chemotherapy, is showing good results when it comes to treating women with metastatic epithelial ovarian cancer.
ascopubs.org

Rationale and study design of the KOV-HIPEC-02R (RECOVER): A randomized, multicenter, open-label phase III trial of cytoreductive surgery and hyperthermic intraperitoneal ...

A phase 3, open-label, randomized study of rinatabart sesutecan (Rina-S) vs investigator’s choice (IC) of chemotherapy in patients with platinum-resistant ovarian cancer (PROC). This is an ASCO ...
ascopubs.org

Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS).

A single-center, open-label, single-arm, phase I study with dose expansion cohort of sacituzumab govitecan in combination with cisplatin for patients with platinum sensitive recurrent ovarian and ...